Warfarin Versus Non–Vitamin K Inhibitor Medications and Cognitive Disease Progression in Atrial Fibrillation
We found similar risks of cognitive decline between those on NOACs or warfarin. Future studies should consider effects of age, length of time from AF diagnosis, and OAC adherence on this risk.
Authors
- Johanna Thunell (ORCID: https://orcid.org/0000-0003-3361-4933)
- Whitney Wharton
- Kathryn Wood (ORCID: https://orcid.org/0000-0003-4671-2014)
- Julie Zissimopoulos
- Yi‐An Ko (ORCID: https://orcid.org/0000-0002-6543-9765)
- Feier Han
Institutions
- University of Southern California (US)
- Emory University (US)
- Woodruff Health Sciences Center (US)
Publication Details
- Journal
- The Journal of Cardiovascular Nursing
- Published
- 2024-12-30
- DOI
- https://doi.org/10.1097/jcn.0000000000001159
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Institute on Aging